Arrowhead Pharmaceuticals, Inc.

Skandinaviska Enskilda Banken AB (publ) ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

159,532

Value ($000)

10,590

Weight

0.0%

2021 Q3 - 2025 Q4 (5 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	10,590	0.0%	159,532	12/31/2025
2022 Q2	8/10/2022	677	0.0%	19,231	6/30/2022
2022 Q1	5/11/2022	313	0.0%	6,816	3/31/2022
2021 Q4	2/10/2022	687	0.0%	10,200	12/31/2021
2021 Q3	11/10/2021	637	0.0%	10,200	9/30/2021